251 related articles for article (PubMed ID: 15191946)
1. New anticoagulants.
Hirsh J; O'Donnell M; Weitz JI
Blood; 2005 Jan; 105(2):453-63. PubMed ID: 15191946
[TBL] [Abstract][Full Text] [Related]
2. New anticoagulants.
Weitz JI; Bates SM
J Thromb Haemost; 2005 Aug; 3(8):1843-53. PubMed ID: 16102051
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials of new anticoagulants.
Anderson J; O'Donnell M
Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
[TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs].
Falciani M; Imberti D; Prisco D
Recenti Prog Med; 2005 Apr; 96(4):196-204. PubMed ID: 15932039
[TBL] [Abstract][Full Text] [Related]
5. New anticoagulants and their potential impact on the treatment of thromboembolic disease.
Ansell J
Curr Hematol Rep; 2004 Sep; 3(5):357-62. PubMed ID: 15341703
[TBL] [Abstract][Full Text] [Related]
6. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
7. New anticoagulants: anti IIa vs anti Xa--is one better?
Bauer KA
J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045
[TBL] [Abstract][Full Text] [Related]
8. Ximelagatran: the first oral direct thrombin inhibitor.
Crowther MA; Weitz JI
Expert Opin Investig Drugs; 2004 Apr; 13(4):403-13. PubMed ID: 15102589
[TBL] [Abstract][Full Text] [Related]
9. New anticoagulants - promising and failed developments.
Harenberg J; Marx S; Krejczy M; Wehling M
Br J Pharmacol; 2012 Jan; 165(2):363-72. PubMed ID: 21740405
[TBL] [Abstract][Full Text] [Related]
10. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
11. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Savelieva I; Bajpai A; Camm AJ
Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
[TBL] [Abstract][Full Text] [Related]
12. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
14. Old and new anticoagulant drugs: a minireview.
Mannucci PM; Franchini M
Ann Med; 2011 Mar; 43(2):116-23. PubMed ID: 21254900
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism.
Agnelli G
Drugs; 2004; 64 Suppl 1():47-52. PubMed ID: 15586627
[TBL] [Abstract][Full Text] [Related]
16. Ximelagatran.
Choudhury A; Goyal D; Lip GY
Drugs Today (Barc); 2006 Jan; 42(1):3-19. PubMed ID: 16511607
[TBL] [Abstract][Full Text] [Related]
17. New anticoagulants for the prevention and treatment of venous thromboembolism.
McRae SJ; Ginsberg JS
Vasc Health Risk Manag; 2005; 1(1):41-53. PubMed ID: 17319097
[TBL] [Abstract][Full Text] [Related]
18. Current issues in anticoagulation.
Agnelli G
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():2-9. PubMed ID: 15812198
[TBL] [Abstract][Full Text] [Related]
19. New anticoagulants.
Bauer KA
Hematology Am Soc Hematol Educ Program; 2006; ():450-6. PubMed ID: 17124098
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.
Bauer KA
J Thromb Haemost; 2011 Jul; 9 Suppl 1():12-9. PubMed ID: 21781237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
